SCHEMBL30962863

SCHEMBL30962863

COc1nc(Cl)ncc1C(=O)Nc1c(Br)cccc1Br

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NFKB1 P19838 2/20 0.42
▸ ATF1 P18846 1/20 0.42
▸ RAB9A P51151 5/20 0.40
▸ NPC1 O15118 4/20 0.40
▸ XPO1 O14980 1/20 0.40
▸ JUN P05412 1/20 0.40
▸ NFKB2 Q00653 1/20 0.40
▸ RELA Q04206 1/20 0.40
▸ KMT2A Q03164 4/20 0.39
▸ PDE4D Q08499 3/20 0.39
▸ PDE4A P27815 2/20 0.39
▸ PDE4B Q07343 2/20 0.39
▸ PDE4C Q08493 2/20 0.39
▸ HPGD P15428 3/20 0.39
▸ HSD17B10 Q99714 3/20 0.39
▸ TSHR P16473 2/20 0.39
▸ SMN1; SMN2 Q16637 2/20 0.39
▸ F2 P00734 1/20 0.39
▸ MAPT P10636 1/20 0.39
▸ PIN1 Q13526 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30962582 0.94 CHRNA7 (0.41) NFKB1ATF1RAB9ANPC1XPO1
SCHEMBL30962625 0.92 PDE4D (0.47) NFKB1ATF1RAB9ANPC1XPO1
SCHEMBL30962872 0.92 NFKB1 (0.39) NFKB1ATF1RAB9ANPC1XPO1
SCHEMBL30962814 0.89 PIN1 (0.45) NFKB1ATF1RAB9ANPC1XPO1
SCHEMBL30962730 0.87 POLB (0.46) NFKB1ATF1RAB9AXPO1KMT2A
SCHEMBL30962894 0.83 CHRNA7 (0.48) NFKB1ATF1RAB9ANPC1KMT2A
SCHEMBL30962909 0.82 GAA (0.46) NPC1XPO1KMT2ATSHRALDH1A1
SCHEMBL30962916 0.82 GAA (0.46) NPC1XPO1KMT2ATSHRALDH1A1
SCHEMBL30962627 0.81 PDE4A (0.43) NFKB1ATF1RAB9AJUNNFKB2
SCHEMBL30962881 0.80 NFKB1 (0.48) NFKB1ATF1XPO1JUNNFKB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4642767-A1 PYRIMIDINE CARBOXAMIDE COMPOUNDS Acrivon Therapeutics, Inc. (US) 2025-11-05 — — EP disclosed
Send feedback